(RITM) Rithm Capital - Overview
Stock: Mortgage Loans, SFR Properties, Securities, Asset Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.91% |
| Yield on Cost 5y | 16.08% |
| Yield CAGR 5y | 2.67% |
| Payout Consistency | 93.1% |
| Payout Ratio | 62.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.1% |
| Relative Tail Risk | -0.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.11 |
| Alpha | -10.83 |
| Character TTM | |
|---|---|
| Beta | 0.767 |
| Beta Downside | 0.939 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.88% |
| CAGR/Max DD | 0.71 |
Description: RITM Rithm Capital January 09, 2026
Rithm Capital Corp. (NYSE:RITM) is a U.S.-based asset manager that operates as a real-estate investment trust (REIT) focused on residential real estate, credit, and related financial-service businesses. It is organized into four segments-Origination & Servicing, Investment Portfolio, Residential Transitional Lending, and Asset Management-holding a diversified mix of single-family rental (SFR) properties, title and appraisal services, property-preservation operations, real-estate securities, and consumer- and business-purpose loans. By distributing at least 90% of its taxable income, the REIT generally avoids federal corporate income tax. The firm, originally New Residential Investment Corp., rebranded to Rithm Capital in August 2022 and has been incorporated since 2011 in New York.
Key recent metrics: the SFR portfolio reported a 96% occupancy rate and a 5% year-over-year rent-growth rate in FY 2023, while cash flow from operations reached roughly $120 million, supporting a dividend yield near 9%. The business benefits from macro trends such as the chronic U.S. housing supply shortage and the shift toward renting among younger households, but it remains sensitive to rising interest rates that can pressure loan-originations and asset valuations. Leverage is modest, with a net asset-to-debt ratio of about 0.8, indicating a relatively resilient balance sheet.
For a deeper dive into RITM’s valuation dynamics and how its metrics compare to peers, you might find ValueRay’s analytical tools useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 886.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.06 > 0.02 and ΔFCF/TA -4.34 > 1.0 |
| NWC/Revenue: -63.47% < 20% (prev 29.04%; Δ -92.51% < -1%) |
| CFO/TA -0.06 > 3% & CFO -2.93b > Net Income 886.6m |
| Net Debt (30.91b) to EBITDA (2.45b): 12.59 < 3 |
| Current Ratio: 0.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (551.3m) vs 12m ago 10.97% < -2% |
| Gross Margin: 92.61% > 18% (prev 0.95%; Δ 9165 % > 0.5%) |
| Asset Turnover: 11.14% > 50% (prev 12.25%; Δ -1.12% > 0%) |
| Interest Coverage Ratio: 1.43 > 6 (EBITDA TTM 2.45b / Interest Expense TTM 1.69b) |
Altman Z'' -0.07
| A: -0.07 (Total Current Assets 1.61b - Total Current Liabilities 4.77b) / Total Assets 47.17b |
| B: 0.00 (Retained Earnings 70.8m / Total Assets 47.17b) |
| C: 0.05 (EBIT TTM 2.41b / Avg Total Assets 44.72b) |
| D: 0.00 (Book Value of Equity 146.1m / Total Liabilities 38.26b) |
| Altman-Z'' Score: -0.07 = B |
Beneish M -2.85
| DSRI: 1.04 (Receivables 3.83b/3.82b, Revenue 4.98b/5.18b) |
| GMI: 1.03 (GM 92.61% / 95.27%) |
| AQI: 1.11 (AQ_t 0.96 / AQ_t-1 0.87) |
| SGI: 0.96 (Revenue 4.98b / 5.18b) |
| TATA: 0.08 (NI 886.6m - CFO -2.93b) / TA 47.17b) |
| Beneish M-Score: -2.85 (Cap -4..+1) = A |
What is the price of RITM shares?
Over the past week, the price has changed by -1.92%, over one month by -3.77%, over three months by +0.16% and over the past year by -1.48%.
Is RITM a buy, sell or hold?
- StrongBuy: 7
- Buy: 4
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RITM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.5 | 35.1% |
| Analysts Target Price | 14.5 | 35.1% |
| ValueRay Target Price | 12.8 | 19.6% |
RITM Fundamental Data Overview February 03, 2026
P/E Forward = 4.9727
P/S = 1.5305
P/B = 0.853
Revenue TTM = 4.98b USD
EBIT TTM = 2.41b USD
EBITDA TTM = 2.45b USD
Long Term Debt = 32.36b USD (from longTermDebt, last quarter)
Short Term Debt = 19.24b USD (from shortTermDebt, last quarter)
Debt = 32.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 30.91b USD (from netDebt column, last quarter)
Enterprise Value = 28.43b USD (6.06b + Debt 32.52b - CCE 10.15b)
Interest Coverage Ratio = 1.43 (Ebit TTM 2.41b / Interest Expense TTM 1.69b)
EV/FCF = -9.68x (Enterprise Value 28.43b / FCF TTM -2.94b)
FCF Yield = -10.33% (FCF TTM -2.94b / Enterprise Value 28.43b)
FCF Margin = -58.97% (FCF TTM -2.94b / Revenue TTM 4.98b)
Net Margin = 17.80% (Net Income TTM 886.6m / Revenue TTM 4.98b)
Gross Margin = 92.61% ((Revenue TTM 4.98b - Cost of Revenue TTM 368.1m) / Revenue TTM)
Gross Margin QoQ = 92.28% (prev 92.77%)
Tobins Q-Ratio = 0.60 (Enterprise Value 28.43b / Total Assets 47.17b)
Interest Expense / Debt = 1.24% (Interest Expense 402.7m / Debt 32.52b)
Taxrate = 3.41% (8.07m / 236.9m)
NOPAT = 2.33b (EBIT 2.41b * (1 - 3.41%))
Current Ratio = 0.34 (Total Current Assets 1.61b / Total Current Liabilities 4.77b)
Debt / Equity = 3.83 (Debt 32.52b / totalStockholderEquity, last quarter 8.50b)
Debt / EBITDA = 12.59 (Net Debt 30.91b / EBITDA 2.45b)
Debt / FCF = -10.53 (negative FCF - burning cash) (Net Debt 30.91b / FCF TTM -2.94b)
Total Stockholder Equity = 8.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.98% (Net Income 886.6m / Total Assets 47.17b)
RoE = 11.08% (Net Income TTM 886.6m / Total Stockholder Equity 8.00b)
RoCE = 5.97% (EBIT 2.41b / Capital Employed (Equity 8.00b + L.T.Debt 32.36b))
RoIC = 5.99% (NOPAT 2.33b / Invested Capital 38.85b)
WACC = 2.38% (E(6.06b)/V(38.58b) * Re(8.74%) + D(32.52b)/V(38.58b) * Rd(1.24%) * (1-Tc(0.03)))
Discount Rate = 8.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.81%
Fair Price DCF = unknown (Cash Flow -2.94b)
EPS Correlation: 9.16 | EPS CAGR: -43.44% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.61 | Revenue CAGR: 10.28% | SUE: 0.58 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.52 | Chg30d=-0.000 | Revisions Net=+0 | Analysts=7
EPS next Year (2026-12-31): EPS=2.25 | Chg30d=+0.036 | Revisions Net=+2 | Growth EPS=+3.7% | Growth Revenue=+16.9%